Works matching IS 03009564 AND DT 2003 AND VI 110 AND IP 11

Results: 12

The neuroprotective effects of Cerebrolysin™ in a transgenic model of Alzheimer’s disease are associated with improved behavioral performance.

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 11, p. 1313, doi. 10.1007/s00702-003-0025-7

By:

Rockenstein, E.;
Adame, A.;
Mante, M.;
Moessler, H.;
Windisch, M.;
Masliah, E.

Publication type:

Article

A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 11, p. 1241, doi. 10.1007/s00702-003-0036-4

By:

Clarke, A.;
Brewer, F.;
Johnson, E. S.;
Mallard, N.;
Hartig, F.;
Taylor, S.;
Corn, T. H.

Publication type:

Article

Spatial correlations between the vacuolation, prion protein deposition and surviving neurons in variant Creutzfeldt-Jakob Disease (vCJD).

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 11, p. 1303, doi. 10.1007/s00702-003-0039-1

By:

Armstrong, R. A.;
Lantos, P. L.;
Ironside, J. W.;
Cairns, N. J.

Publication type:

Article

Distribution of the NPY 1128C allele frequency in different populations.

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 11, p. 1199, doi. 10.1007/s00702-003-0034-6

By:

Ding, B.

Publication type:

Article

Activation of basal ganglia loops in idiopathic Parkinson’s disease: a PET study.

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 11, p. 1289, doi. 10.1007/s00702-003-0041-7

By:

Thiel, A.;
Hilker, R.;
Kessler, J.;
Habedank, B.;
Herholz, K.;
Heiss, W.-D.

Publication type:

Article

Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system.

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 11, p. 1215, doi. 10.1007/s00702-003-0045-3

By:

Gajjar, T. M.;
Anderson, L. I.;
Dluzen, D. E.

Publication type:

Article

Mutation analysis of the zinc transporter gene SLC30A4 reveals no association with periodic catatonia on chromosome 15q15.

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 11, p. 1329, doi. 10.1007/s00702-003-0060-4

By:

Küry, S.;
Rubie, C.;
Moisan, J. P.;
Stöber, G.

Publication type:

Article

Selegiline’s neuroprotective capacity revisited.

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 11, p. 1273, doi. 10.1007/s00702-003-0083-x

By:

Riederer, P.;
Lachenmayer, L.

Publication type:

Article

Expression of cannabinoid CB<sub>1</sub> receptor mRNA in basal ganglia of normal and parkinsonian human brain.

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 11, p. 1279, doi. 10.1007/s00702-003-0033-7

By:

Hurley, M. J.;
Mash, D. C.;
Jenner, P.

Publication type:

Article

A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition.

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 11, p. 1257, doi. 10.1007/s00702-003-0042-6

By:

Clarke, A.;
Johnson, E. S.;
Mallard, N.;
Corn, T. H.;
Johnston, A.;
Boyce, M.;
Warrington, S.;
MacMahon, D. G.

Publication type:

Article

Selegiline reduces N-methyl-D-aspartic acid induced perturbation of neurotransmission but it leaves NMDA receptor dependent long-term potentiation intact in the hippocampus.

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 11, p. 1225, doi. 10.1007/s00702-003-0035-5

By:

Niittykoski, M.;
Haapalinna, A.;
Sirviö, J.

Publication type:

Article

The interaction of tetrahydroisoquinoline derivatives with antinociceptive action of morphine and oxotremorine in mice.

Published in:

Journal of Neural Transmission, 2003, v. 110, n. 11, p. 1205, doi. 10.1007/s00702-003-0037-3

By:

Vetulani, J.;
Pavone, F.;
Przewłocka, B.;
Borghi, V.;
Nalepa, I.

Publication type:

Article